Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature

By G. Rice, P. Kasher, G. Forte, Niamh M. Mannion, Sam M Greenwood, M. Szynkiewicz, Jonathan E. Dickerson, S. Bhaskar, M. Zampini, T. Briggs and 44 more. Nature Genetics, 2012

864 citations recorded by the source corpus.

Adenosine deaminases acting on RNA (ADARs) catalyze the hydrolytic deamination of adenosine to inosine in double-stranded RNA (dsRNA) and thereby potentially alter the information content and structure of cellular RNAs. Notably, although the overwhelming majority of such editing events occur in transcripts derived from Alu repeat elements, the biological function of non-coding RNA editing remains uncertain. Here, we show that mutations in ADAR1 (also known as ADAR) cause the autoimmune disorder Aicardi-Goutières syndrome (AGS). As in Adar1-null mice, the human disease state is associated with upregulation of interferon-stimulated genes, indicating a possible role for ADAR1 as a suppressor of type I interferon signaling. Considering recent insights derived from the study of other AGS-related proteins, we speculate that ADAR1 may limit the cytoplasmic accumulation of the dsRNA generated from genomic repetitive elements.

Subfields: Immunology, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/a34f563300adec7bf9bacc75d821ed7ca61f72e8

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

  1. Thomas Tuschl
  2. M. Hafner
  3. S. Gerstberger
  4. David P. Bartel
  5. Phillip D. Zamore
  6. Phillip A. Sharp
  7. Weimin He
  8. Gregory J. Hannon

Citations in the corpus